C. Bifulco

发表

SYSTEMATIC CLASSIFICATION OF DROUGHT VULNERABILITY AND RELEVANT STRATEGIES - CASE STUDY SCALE

A. Solera, J. Andréu, D. Assimacopoulos, 2015 .

Oncogenic Signaling Pathways in The Cancer Genome Atlas.

Steven J. M. Jones, Christopher A. Miller, Joshua M. Stuart, 2018, Cell.

Pathogenic Germline Variants in 10,389 Adult Cancers.

Steven J. M. Jones, Benjamin J. Raphael, Joshua F. McMichael, 2018, Cell.

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

Steven J. M. Jones, Christopher A. Miller, Joshua M. Stuart, 2018, Cancer cell.

Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity

S. Prahl, B. Fox, C. Bifulco, 2020, Journal of Clinical and Translational Science.

Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity

S. Prahl, B. Fox, C. Bifulco, 2020, Journal of Clinical and Translational Science.

Cancer classification using the Immunoscore: a worldwide task force

F. Marincola, P. Gibbs, M. Mihm, 2012, Journal of Translational Medicine.

Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours

F. Marincola, P. Gibbs, P. Delrio, 2013, The Journal of pathology.

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

F. Marincola, D. Sargent, P. Delrio, 2018, The Lancet.

Impacts of European drought events: insights from an international database of text-based reports

K. Stahl, L. Tallaksen, D. Assimacopoulos, 2015 .

Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer

C. Dubay, Brady Bernard, B. Piening, 2020, PloS one.

Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma

Bernard A. Fox, Chichung Wang, B. Fox, 2015, Journal of Immunotherapy for Cancer.

World-Wide Immunoscore Task Force: meeting report from the “Melanoma Bridge”, Napoli, November 30th–December 3rd, 2016

F. Marincola, P. Ascierto, J. Galon, 2017, Journal of Translational Medicine.

Comprehensive Characterization of Cancer Driver Genes and Mutations

Steven J. M. Jones, Christopher A. Miller, Joshua M. Stuart, 2018, Cell.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

Preanalytic Variables and Tissue Stewardship for Reliable Next-Generation Sequencing (NGS) Clinical Analysis.

Giuseppe Palmieri, Paolo A. Ascierto, P. Ascierto, 2019, The Journal of molecular diagnostics : JMD.

Impact of meteorological drought on crop yield on pan-European scale, 1979-2009

F. Rego, C. Bifulco, S. Dias, 2015 .

The Society for Immunotherapy in Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation

J. Taube, I. Wistuba, Emanuel Schenck, 2020, Journal for immunotherapy of cancer.

Miniatures Sustained Complete Response to CTLA-4 Blockade in a Patient with Metastatic , Castration-Resistant Prostate Cancer

B. Fox, C. Bifulco, T. Beer, 2014 .

Sustained Complete Response to CTLA-4 Blockade in a Patient with Metastatic, Castration-Resistant Prostate Cancer

B. Fox, C. Bifulco, T. Beer, 2014, Cancer Immunology Research.

Novel frontiers in detecting cancer metastasis

B. Fox, C. Bifulco, S. Leong, 2018, Clinical & Experimental Metastasis.

Telepathology and pathology at distance: an overview.

D. Jukic, C. Bifulco, 1999, Croatian medical journal.

Development of an electronic breast pathology database in a community health system

J. Elmore, D. Weaver, H. Nelson, 2014, Journal of pathology informatics.

To count and how to count, that is the question: interobserver and intraobserver variability among pathologists in lymph node counting.

J. Concato, D. Jain, R. Feinn, 2010, American journal of clinical pathology.

Multispectral Fluorescence Imaging Allows for Distinctive Topographic Assessment and Subclassification of Tumor-Infiltrating and Surrounding Immune Cells.

B. Seliger, B. Fox, D. Bethmann, 2019, Methods in molecular biology.

2 – Cellular and Molecular Pathology

C. Bifulco, Hongling. Xiao, Hong D. Xiao, 2018 .

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment

F. Marincola, G. Botti, P. Ascierto, 2013, Journal of Translational Medicine.

AN IMMUNOTHERAPY TRIO IN ADVANCED FOR COORDINATED

F. Lund-Johansen, B. Fox, B. Piening, 2020 .

The Great Debate at ‘Immunotherapy Bridge’, Naples, December 5, 2019

P. Ascierto, G. Trinchieri, J. McQuade, 2020, Journal for ImmunoTherapy of Cancer.

Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma.

M. Corbellino, L. Poirel, E. Berti, 1996, AIDS research and human retroviruses.

Lack of Immunohistochemical Detection of VEGF in Prostate Carcinoma

J. Concato, D. Jain, C. Bifulco, 2009, Applied immunohistochemistry & molecular morphology : AIMM.

Validation of the Immunoscore (IM) as a prognostic marker in stage I/II/III colon cancer: Results of a worldwide consortium-based analysis of 1,336 patients.

D. Sargent, P. Ascierto, B. Fox, 2016 .

Cumulative suppressive index as a predictor of relapse free survival and overall survival in Human Papilloma Virus‐negative oral squamous cell carcinomas with negative resection margins

B. Seliger, B. Fox, D. Bethmann, 2020, Head & neck.

Comprehensive Characterization of Cancer Driver Genes and Mutations

Steven J. M. Jones, Christopher A. Miller, Joshua M. Stuart, 2018, Cell.

Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021

Tamara J Laskowski, J. Taube, P. Ascierto, 2022, Journal of Translational Medicine.

Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients.

B. Fox, R. Pierce, A. Daud, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study

F. Marincola, P. Delrio, J. Lee, 2022, Cancers.

Improving Drought Preparedness in Portugal

F. Rego, C. Bifulco, S. Dias, 2018 .

Circulating and intratumoral macrophages in patients with hepatocellular carcinoma: correlation with therapeutic approach.

T. Crocenzi, C. Bifulco, P. Newell, 2013, American journal of surgery.

Extranodal Marginal Zone B-Cell Lymphoma/Maltoma of the Lip in a Child

C. Bifulco, Joseph Shin, E. Zambrano, 2006, International journal of surgical pathology.

PCM1-JAK2 Fusion Tyrosine Kinase Gene-Related Neoplasia: A Systematic Review of the Clinical Literature

C. Bifulco, H. Kaplan, J. Scanlan, 2022, The oncologist.

Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma.

D. Jain, L. Ferrell, M. Yeh, 2009, Human pathology.

Identical rearrangement of immunoglobulin heavy chain gene in neoplastic Langerhans cells and B-lymphocytes: evidence for a common precursor.

S. Pilotti, J. Rosai, C. Bifulco, 2002, Leukemia research.

CD4+ T cells mediate mucosal and systemic immune responses to experimental hookworm infection

C. Bifulco, M. Cappello, L. Harrison, 2010, Parasite immunology.

Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma

R. Bell, W. Urba, C. Bifulco, 2021, Journal for ImmunoTherapy of Cancer.

Unmasking PD-1 Resistance by Next-Generation Sequencing.

W. Urba, C. Bifulco, 2016, The New England journal of medicine.

Centroblasts In Vivo The A-Myb Transcription Factor Is a Marker of

A. Pizzey, D. Delia, C. Bifulco, 1998 .

Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone.

C. Bifulco, C. Carlo-Stella, M. Di Nicola, 2004, Experimental hematology.

A Random Forest Genomic Classifier for Tumor Agnostic Prediction of Response to Anti-PD1 Immunotherapy

S. Saria, E. Jaffee, E. Fertig, 2022, Cancer informatics.

Treatment of PCM1-JAK2 fusion tyrosine kinase gene-related acute lymphoblastic leukemia with stem cell transplantation

C. Bifulco, H. Kaplan, J. Scanlan, 2021 .

Tumor growth-promoting properties of macrophage migration inhibitory factor.

L. Leng, R. Bucala, C. Bifulco, 2008, Current pharmaceutical design.

Preliminary Results of a Phase 1 Study of Flotetuzumab, a CD123 x CD3 Bispecific Dart® Protein, in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome

B. Fox, J. Dipersio, J. Wigginton, 2017 .

A novel regimen incorporating the concomitant administration of fludarabine and alemtuzumab for the treatment of refractory adult acute lymphoblastic leukaemia: a report of three cases

C. Bifulco, G. Vanasse, A. Parnes, 2007, British journal of haematology.

Cancer microenvironment and genomics: evolution in process

Melissa B. Davis, Lauren M. Sanders, D. Haussler, 2021, Clinical & Experimental Metastasis.

Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sections

Johannes Gerdes, Giorgio Cattoretti, Stefano Pileri, 1993, The Journal of pathology.

The A-Myb transcription factor is a marker of centroblasts in vivo.

C Bifulco, A. Pizzey, D. Delia, 1998, Journal of immunology.

DROUGHT INDICATORS: MONITORING, FORECASTING AND EARLY WARNING AT THE CASE STUDY SCALE

A. Solera, J. Andréu, D. Assimacopoulos, 2015 .

Role for Nitric Oxide in Hookworm-Associated Immune Suppression

C. Bifulco, D. Mcmahon-Pratt, M. Cappello, 2008, Infection and Immunity.

Clinical and dermatoscopic diagnosis of small pigmented skin lesions.

C. Bartoli, C. Bifulco, S. Tomatis, 2002, European journal of dermatology : EJD.

Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”: Napoli, December 3rd–6th 2014

Martin F. Mihm, B. Schilling, F. Marincola, 2013, Journal of Translational Medicine.

Cartilaginous Differentiation in Peritoneal Tissues: A Report of Two Cases and a Review of the Literature

C. Bifulco, D. Carter, O. Fadare, 2002, Modern Pathology.

Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

Clement Adebamowo, Ritika Kundra, Steven J. M. Jones, 2018, Cell reports.

Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers.

Brady Bernard, B. Piening, J. Fass, 2022, Cancer cell.

Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma

B. Fox, R. Pierce, M. Pittet, 2020, Clinical Cancer Research.

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

K. Harrington, N. Lee, R. Ferris, 2019, Journal of Immunotherapy for Cancer.

Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy)

P. Ascierto, C. Gridelli, H. Zarour, 2018, Journal of Immunotherapy for Cancer.

Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November–2 December, 2017, Naples, Italy)

F. Marincola, G. Botti, P. Ascierto, 2018, Journal of Translational Medicine.

Novel frontiers in detecting cancer metastasis

B. Fox, C. Bifulco, S. Leong, 2018, Clinical & Experimental Metastasis.

Immunotherapy in Head and Neck Cancers

B. Fox, R. Bell, C. Bifulco, 2016 .

Multispectral Imaging of T and B Cells in Murine Spleen and Tumor

Michael Neuberger, B. Fox, C. Bifulco, 2016, The Journal of Immunology.

Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer

C. Dubay, Brady Bernard, B. Piening, 2021, Oncoimmunology.

Genotypic Analysis of Hydatidiform Mole: An Accurate and Practical Method of Diagnosis

C. Bifulco, P. Hui, S. Bell, 2008, The American journal of surgical pathology.

Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer

F. Marincola, P. Delrio, J. Lee, 2023, Cancers.

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.

F. Marincola, P. Delrio, G. Botti, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Histopathologic and Molecular Aspects of CD56+ Natural Killer/ T-Cell Lymphoma of the Testis

D. Braddock, C. Bifulco, J. G. Howe, 2008, International journal of surgical pathology.

Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021

Tamara J Laskowski, J. Taube, P. Ascierto, 2022, Journal of translational medicine.

Overexpression of SOCS3 is associated with decreased survival in a cohort of patients with de novo follicular lymphoma

C. Bifulco, G. Vanasse, A. Zieske, 2006, British journal of haematology.

Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015

F. M. Marincola, F. Marincola, G. Botti, 2016, Journal of Translational Medicine.

Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence

Annette Lee, P. Gregersen, K. Iczkowski, 2007, Genes and Immunity.

Genomic heterogeneity and clinical characterization of SARS-CoV-2 in Oregon

B. Piening, W. Urba, C. Bifulco, 2020, medRxiv.

Cancer microenvironment and genomics: evolution in process

Lauren M. Sanders, D. Haussler, L. Newman, 2021, Clinical & Experimental Metastasis.

Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810

I. Lowy, B. Piening, C. Bifulco, 2016, Journal of Immunotherapy for Cancer.

Multiparametric immune profiling in HPV- oral squamous cell cancer.

Tuan Bui, Carmen Ballesteros-Merino, Clifford Hoyt, 2017, JCI insight.

Adoptive TIL in HPV-negative oral scca

B. Fox, R. Bell, W. Urba, 2015, Journal of Immunotherapy for Cancer.

Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma

B. Fox, M. Tinguely, C. Bifulco, 2012, Gene Therapy.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd–3rd, 2020, Italy)

J. Taube, P. Ascierto, J. McQuade, 2021, Journal of Translational Medicine.

Immunoprofiling for Prognostic Assessment of Colon Cancer: a Novel Complement to Ultrastaging

B. Fox, A. Stojadinovic, Z. Wainberg, 2015, Journal of Gastrointestinal Surgery.

Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”, Napoli, December 5th-8th 2013

B. Schilling, F. Marincola, R. Sullivan, 2014, Journal of Translational Medicine.

PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab

Gerardo Botti, Mariaelena Capone, Carmen Ballesteros-Merino, 2017, Oncoimmunology.

Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti–PD-1 Therapy

B. Fox, R. Pierce, C. Acharya, 2021, Clinical Cancer Research.

Do patients with tumor-positive sentinel nodes constitute a homogeneous group?

N. Cascinelli, A. Morabito, C. Bifulco, 2001, Annals of surgical oncology.

Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment

B. Fox, C. Bifulco, B. Curti, 2015, Journal of Immunotherapy for Cancer.

FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies

B. Fox, B. Piening, C. Bifulco, 2023, bioRxiv.

Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells

B. Fox, Brady Bernard, R. Bell, 2021, Nature Communications.

Preliminary Translational Results from an Ongoing Phase 1 Study of Flotetuzumab, a CD123 x CD3 Dart®, in AML/MDS: Rationale for Combining Flotetuzumab and Anti-PD-1/PD-L1 Immunotherapies

B. Fox, J. Dipersio, P. Moore, 2017 .

Soil and water bioengineering: Practice and research needs for reconciling natural hazard control and ecological restoration.

F Rey, C Bifulco, G B Bischetti, 2019, The Science of the total environment.

Towards Structuring Real-World Data at Scale: Deep Learning for Extracting Key Oncology Information from Clinical Text with Patient-Level Supervision

Paul D. Tittel, Hoifung Poon, Naveen Valluri, 2022, ArXiv.

Assessing the association of drought indicators to impacts: the results for areas burned by wildfires in Portugal

F. Rego, C. Bifulco, S. Dias, 2014 .

Different cytokeratin and neuronal cell adhesion molecule staining patterns in focal nodular hyperplasia and hepatic adenoma and their significance.

D. Jain, R. Salem, C. Bifulco, 2008, Human pathology.

Editorial: Mechanisms of Lymphocyte Exclusion in the Tumor Microenvironment

C. Bifulco, J. Luke, S. Church, 2022, Frontiers in Immunology.

MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab

Gerardo Botti, Paolo A Ascierto, Gennaro Ciliberto, 2014, Journal of Translational Medicine.

Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015

M. Capone, G. Botti, P. Ascierto, 2016, Journal of Translational Medicine.

Likelihood of future drought hazards: selected European case studies

A. Solera, J. Andréu, D. Assimacopoulos, 2013 .

Toward structuring real-world data: Deep learning for extracting oncology information from clinical text with patient-level supervision

Rajesh N. Rao, Paul D. Tittel, Hoifung Poon, 2023, Patterns.

Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis

Allison P. Heath, Marilyn M. Li, Jena V. Lilly, 2022, Scientific Reports.

Serum immunoregulatory proteins as predictors of overall survival of metastatic melanoma patients treated with ipilimumab

B. Fox, A. Korman, W. Urba, 2015, Journal of Immunotherapy for Cancer.

World-Wide Immunoscore Task Force: meeting report from the “Melanoma Bridge”, Napoli, November 30th–December 3rd, 2016

F. Marincola, P. Ascierto, J. Galon, 2017, Journal of Translational Medicine.

MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab

G. Madonna, M. Capone, G. Botti, 2014, Journal of Translational Medicine.

Immunoscore clinical utility to identify good prognostic colon cancer stage II patients with high-risk clinico-pathological features for whom adjuvant treatment may be avoided.

F. Marincola, P. Ascierto, I. Nagtegaal, 2019, Journal of Clinical Oncology.

Neoadjuvant anti-OX40 (MEDI6469) prior to surgery in head and neck squamous cell carcinoma.

B. Fox, Brady Bernard, R. Bell, 2018 .

Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022)

P. Ascierto, T. Kirchhoff, B. Fox, 2023, Journal of Translational Medicine.

A EUROPEAN DROUGHT IMPACT REPORT INVENTORY (EDII): DESIGN AND TEST FOR SELECTED RECENT DROUGHTS IN EUROPE

K. Stahl, L. Tallaksen, D. Assimacopoulos, 2012 .

Scaling Clinical Trial Matching Using Large Language Models: A Case Study in Oncology

Hoifung Poon, B. Piening, Tristan Naumann, 2023, ArXiv.

Significant differences in outcome between Immunoscore categories in stage I colon cancer patients.

F. Marincola, P. Ascierto, I. Nagtegaal, 2019, Annals of Oncology.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

Conservation status of Chirocephalus marchesonii Ruffo & Vesentini, 1957 in the Pilato Lake (Sibillini Mountains National Park, Central Italy)

C. Bifulco, A. Ambrosi, A. Carosi, 2020 .

Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”: Napoli, December 3rd–6th 2014

Martin F. Mihm, B. Schilling, F. Marincola, 2013, Journal of Translational Medicine.

Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC

C. Dubay, B. Fox, B. Spieler, 2015, Journal of Immunotherapy for Cancer.

Genotypic Analysis of Hydatidiform Mole: An Accurate and Practical Method of Diagnosis

C. Bifulco, P. Hui, S. Bell, 2008, The American journal of surgical pathology.

MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies

F. Marincola, P. Ascierto, I. Nagtegaal, 2018, Annals of Oncology.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, David M. Schauder, 2016, Journal for ImmunoTherapy of Cancer.

Flotetuzumab (FLZ), an Investigational CD123 x CD3 Bispecific Dart® Protein-Induced Clustering of CD3+ T Cells and CD123+ AML Cells in Bone Marrow Biopsies Is Associated with Response to Treatment in Primary Refractory AML Patients

B. Fox, J. Wigginton, C. Bifulco, 2019, Blood.

Multi-Institutional Evaluation of Pathologists’ Assessment Compared to Immunoscore

J. Galon, S. Demaria, C. Bifulco, 2023, Cancers.

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

R. Ferris, Q. Le, A. Raben, 2019, Journal of Immunotherapy for Cancer.